LinkedIn Profile

Access Integrity Applications historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:integrityapplications 664494 May 29th, 2019 12:00AM Integrity Applications (IGAP) 429 27.00 Open Medical Devices May 29th, 2019 12:26AM May 29th, 2019 12:26AM Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea. The company went public in November 2011 and is currently traded over the counter as (OTCQB: IGAP). Open GlucoTrack - Non-Invasive glucose monitor for home use Open 19 Ha'Yahalomim St., P.O. Box 12163 Ashdod IL 7760049 Integrity Applications Health Care Health Care Equipment & Services
private:integrityapplications 664494 Mar 26th, 2018 12:00AM Integrity Applications (IGAP) 364 36.00 Open Medical Devices Mar 26th, 2018 05:16PM Mar 26th, 2018 05:16PM Open Integrity Applications Health Care Health Care Equipment & Services
private:integrityapplications 664494 Feb 17th, 2018 12:00AM Integrity Applications (IGAP) 343 39.00 Open Medical Devices Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea. The company went public in November 2011 and is currently traded over the counter as (OTCQB: IGAP). Integrity Applications Health Care Health Care Equipment & Services
private:integrityapplications 664494 Feb 16th, 2018 12:00AM Integrity Applications (IGAP) 343 39.00 Open Medical Devices Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea. The company went public in November 2011 and is currently traded over the counter as (OTCQB: IGAP). Integrity Applications Health Care Health Care Equipment & Services
private:integrityapplications 664494 Feb 15th, 2018 12:00AM Integrity Applications (IGAP) 343 39.00 Open Medical Devices Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea. The company went public in November 2011 and is currently traded over the counter as (OTCQB: IGAP). Integrity Applications Health Care Health Care Equipment & Services
private:integrityapplications 664494 Feb 14th, 2018 12:00AM Integrity Applications (IGAP) 343 39.00 Open Medical Devices Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea. The company went public in November 2011 and is currently traded over the counter as (OTCQB: IGAP). Integrity Applications Health Care Health Care Equipment & Services
private:integrityapplications 664494 Feb 13th, 2018 12:00AM Integrity Applications (IGAP) 343 39.00 Open Medical Devices Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea. The company went public in November 2011 and is currently traded over the counter as (OTCQB: IGAP). Integrity Applications Health Care Health Care Equipment & Services
private:integrityapplications 664494 Feb 12th, 2018 12:00AM Integrity Applications (IGAP) 343 39.00 Open Medical Devices Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea. The company went public in November 2011 and is currently traded over the counter as (OTCQB: IGAP). Integrity Applications Health Care Health Care Equipment & Services
private:integrityapplications 664494 Feb 11th, 2018 12:00AM Integrity Applications (IGAP) 343 39.00 Open Medical Devices Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea. The company went public in November 2011 and is currently traded over the counter as (OTCQB: IGAP). Integrity Applications Health Care Health Care Equipment & Services
private:integrityapplications 664494 Feb 10th, 2018 12:00AM Integrity Applications (IGAP) 343 39.00 Open Medical Devices Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea. The company went public in November 2011 and is currently traded over the counter as (OTCQB: IGAP). Integrity Applications Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.